NYU Cancer Center — New York, New York

NYU Cancer Center is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

NYU Cancer Center has participated in 15 clinical trials with 1 currently active.

Therapeutic areas: Non-Small Cell Lung Cancer (NSCLC), Multiple Myeloma, Breast Cancer.

Sponsors: Hoffmann-La Roche, NYU Langone Health, Incyte Corporation.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU Cancer Center?

NYU Cancer Center has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU Cancer Center conducted?

NYU Cancer Center has 15 clinical trials on record, with 1 currently active. Their work covers Non-Small Cell Lung Cancer (NSCLC), Multiple Myeloma, Breast Cancer.

Is NYU Cancer Center accredited by Crixeo Health?

Yes — NYU Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about NYU Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.